Atlas Trials

Brii Biosciences Limited

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Brii Biosciences Limited

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE) (NCT06650852)Brii Biosciences Limited2024-10-31
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH) (NCT06491563)Brii Biosciences Limited2024-08-06
A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) (NCT06057012)Brii Biosciences Limited2023-09-29
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients (NCT05970289)Brii Biosciences Limited2023-08-22
A Study of BRII-297 in Healthy Adult Subjects (NCT05845840)Brii Biosciences Limited2023-05-15
A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 (NCT04787211)Brii Biosciences Limited2021-06-20
Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection (NCT04749368)Brii Biosciences Limited2021-04-12
A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 (NCT04691180)Brii Biosciences Limited2021-01-05
Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China (NCT04507269)Brii Biosciences Limited2020-08-18
Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198 (NCT04479644)Brii Biosciences Limited2020-07-13
Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196 (NCT04479631)Brii Biosciences Limited2020-07-12

Track Brii Biosciences Limited automatically

Every clearance here is in the API, with alerts when new ones post.